外周T细胞淋巴瘤的药物治疗进展
摘要
外周T细胞淋巴瘤(FFCL)为异质性血液学肿瘤组,起源于成熟T细胞,预后较差。目前该病的治疗尚处于探索阶段,很多新药的研究正在进行,新的药物组合方案的尝试也已展开,从很大程度上提高了该类患者的临床疗效与预后。本文着重于探索目前PTCL的药物治疗进展。
出处
《徐州医学院学报》
CAS
2012年第4期277-280,共4页
Acta Academiae Medicinae Xuzhou
参考文献22
-
1Savage K J, FelTeri A J, Zinzani PL, et al. Peripheral T - cell lym- phoma - - not otherwise specified [ J ]. Crit Rev Oncol Hemat, 2011,79 ( 3 ) :321 - 329.
-
2Piekarz RL, Frye R, Prince HM, et al. Phase 2 trial of romidep- sin in patients with peripheral T - cell lymphoma [ J ]. Blood, 2011,117(22) :5827 -5834.
-
3Armitage J, Vose J, Weisenburger D. International peripheral T - cell and natural killer/T - cell lymphoma study : pathology findings and clinical outcomes [ J ]. J Clin Oncol, :2008, 26 (25) :4124 - 4130.
-
4Sehmitz N, T~imper L, Ziepert M, et al. Treatment and prognosis of mature T - cell and NK - cell lymphoma: analysis of patients with T - cell lymphoma treated in studies of the German High - Grade Non- Hodgkin Lymphoma Study Group [J]. Blood, 2010, 116(18) : 3418 -3425.
-
5Zelenetz AD, Abramson JS, Advani RH, et al. NCCN Clinical Practice Guidelines in Oncology: non - Hodgkin' s lymphomas [J]. J Natl Compr Canc Netw, 2010, 8(3) :288 -334.
-
6Zinzani PL, Venturini F, Stefoni V, et al. Gemcitabine as single agent in pretreated T - cell lymphoma patients : evaluation of the long - term outcome [ J]. Ann Oncol, 2010,21 (4) :860 - 863.
-
7王学文,李锋.外周T细胞淋巴瘤的研究进展[J].现代肿瘤医学,2009,17(6):1173-1178. 被引量:10
-
8O'Connor OA, Pro B, Pinter - Brown L, et al. Pralatrexate in pa- tients with relapsed or refractory peripheral T - cell lymphoma : re- suits from the pivotal PROPEL study [ J]. J Clin Oncol,2011,29 (9) :1182 - 1189.
-
9Mould DR, Sweeney K, Duffull SB, et al. A population pharma- cokinetic and phammcodynamic evaluation of pralatrexate in pa- tients with relapsed or refractory non - Hodgkin' s or Hodgkin' s lymphoma [ J ]. Clin Pharmacol Ther, 2009,86 ( 2 ) : 190 - 196.
-
10Dang NH, Pro B, Hagemeister FB, et al. Phase II trial of de- nileukin diftitox for relapsed/refractory T - cell non - Hodgkin lymphoma [Jl. Br J Haematol, 2007,136(3):439-447.
二级参考文献35
-
1The Non-Hodgkin's Lymphoma Classification Project.A clinical evaluation of the International Lymphoma Study Group classication of non-Hodgkin's lymphoma[J].Blood,1997,89(11):3909-3918.
-
2Vose JM.International Peripheral T-cell Lymphoma(PTCL)Clinical and Pathologic Review Project:poor outcome by prognostic indices and lack of efficacy with anthracyclines[J].Blood,2005,1006(11):239.
-
3Rudiger T,Geissinger E,Muller-Hermelink HK.Normal counterparts' of nodal peripheral T-cell lymphoma[J].Hematol Oncol,2006,24(4):175-180.
-
4Delves PJ,Roitt IM.The immune system.Second of two parts[J].N Engl J Med,2000,343(2):108-117.
-
5Delves PJ,Roitt IM.The immune system.First of two parts[J].N Engl J Med,2000,343(1):37-49.
-
6Stein H,Foss HD,Durkop H,et al.CD30(+)anaplastic large cell lymphoma:a review of its histopathologic,genetic,and clinical features[J].Blood,2000,97(12):3681-3695.
-
7Chen CY,Yao M,Tang JL,et al.Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan:with special reference to T-cell lymphoma[J].Ann Oncol,2004,15(7):1091-1096.
-
8Martinez-Delgado B,Cuadros M,Honrado E,et al.Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas[J].Leukemia,2005,19(12):2254-2263.
-
9Ralfkiaer E,Muller-Hermelink HK,Jaffe ES.Peripheral T-cell lymphoma,unspecified[A].Jaffe ES,Harris NL,Stein H,et al.World Health Organization classification of tumours.Pathology and genetics of tumours of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2001:227-229.
-
10Armitage JO,Cavalli F,Zucca E,eds.Text atlas of lymphomas(revised edition)[M].London:Martin Dunitz,2002:30-43.
共引文献9
-
1王亮,丛宪玲,佟雅军,蒋忠民.DNA甲基化异常与皮肤肿瘤[J].中国实验诊断学,2009,13(12):1812-1814.
-
2刘瑜.EB病毒相关外周T细胞淋巴瘤1例[J].第三军医大学学报,2010,32(1):29-29.
-
3赵征,王军,雷宝霞,廖子君.GDP方案治疗复发难治外周T细胞淋巴瘤临床观察[J].现代肿瘤医学,2010,18(11):2233-2234. 被引量:2
-
4黄细莲,钱申贤,高大泉,谢亚萍,谭俊峰,施鹏飞,刘利蓉,陈况.硼替佐米联合化疗治疗复发难治外周T细胞淋巴瘤3例[J].临床血液学杂志,2011,24(1):56-57. 被引量:6
-
5邱金鑫,向亚娟,缪艳.硼替佐米治疗难治性非霍奇金淋巴瘤不良反应的观察与护理[J].全科护理,2011,9(31):2868-2869.
-
6刘永钟,梁淑仪,彭杰文,梁汉霖,殷兆锋,贺景焕.GDP方案治疗复发和难治性弥漫性大B细胞淋巴瘤的疗效分析[J].中国肿瘤临床与康复,2011,18(6):519-522. 被引量:2
-
7刘永钟,梁淑仪,林贵南,彭杰文,殷兆锋,梁汉霖,贺景焕.吉西他滨联合奥沙利铂治疗复发和难治性弥漫性大B细胞淋巴瘤的疗效观察[J].中国医药,2012,7(11):1391-1393.
-
8卢家桀,唐红.以皮肤瘙痒为首发症状的外周T细胞淋巴瘤一例[J].华西医学,2014,29(4):797-797.
-
9赵倩,屈慧新,史慧静,王彩霞.治疗复发或难控型外周T细胞淋巴瘤新药——贝林司他[J].医药导报,2016,35(5):551-554. 被引量:2
-
1吴文成.垂体瘤的药物治疗进展[J].国外医学(内分泌学分册),1990,10(2):72-75.
-
2王晖,刘心.多发性骨髓瘤的发病机制及药物治疗进展[J].国际病理科学与临床杂志,2006,26(5):403-406. 被引量:6
-
3罗思红.慢性髓细胞白血病的药物治疗进展[J].北方药学,2013,10(8):49-49.
-
4黄健(综述),王晓稼(审校).晚期乳腺癌分子靶向药物治疗进展[J].国际肿瘤学杂志,2008,35(3):189-192.
-
5张庆利.化疗所致胃肠道反应的药物治疗进展[J].中国社区医师,2002,18(8):8-8.
-
6闫志华.乳腺癌的药物治疗进展[J].山西医药杂志,2007,36(8):720-722.
-
7王兵(综述),于甬华(审校).胆道系统癌药物治疗进展[J].国际肿瘤学杂志,2009,36(8):619-621.
-
8黄镜.晚期食管癌的药物治疗进展[J].中国临床研究,2010,23(1):1-4. 被引量:7
-
9贾臻,胡夕春.乳腺癌的药物治疗进展[J].世界临床药物,2011,32(8):511-512. 被引量:3
-
10龚新雷,秦叔逵.胰腺癌的药物治疗进展[J].临床肿瘤学杂志,2007,12(1):68-76. 被引量:8